Key points are not available for this paper at this time.
Toll-like receptor (TLR)-7/8 agonists are promising candidates for the development of new-generation vaccine adjuvants. Adsorption of TLR7/8 agonists on aluminum salts (alum) may further enhance vaccine immunogenicity. Evaluation of the adjuvanticity of the most active dual TLR7/8 agonists, 1-(3-(aminomethyl)benzyl)-2-butyl-1
Building similarity graph...
Analyzing shared references across papers
Loading...
Kushvinder Kumar
Centre of Advanced Studies
Yoshikazu Honda‐Okubo
South Australia Pathology
Isaac G. Sakala
South Australia Pathology
ACS Medicinal Chemistry Letters
Panjab University
Vaxine (Australia)
Australian Respiratory and Sleep Medicine Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Kumar et al. (Mon,) studied this question.
synapsesocial.com/papers/68e5f73ab6db64358758bcd5 — DOI: https://doi.org/10.1021/acsmedchemlett.4c00200
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: